Mikamo H, Kawazoe K, Sato Y, Hayasaki Y, Izumi K, Tamaya T
Department of Obstetrics and Gynecology, School of Medicine, Gifu University, Japan.
Chemotherapy. 1998 Jul-Aug;44(4):238-42. doi: 10.1159/000007120.
AM-1155 is a new 8-methoxyquinolonecarboxylic acid with a broad spectrum of antibacterial activity. It inhibited more than 90% of clinical isolates of Streptococcus agalactiae, Escherichia coli, Peptostreptococcus magnus, Bacteroides fragilis and Prevotella bivia at the concentration of 3.13 mg/l. The antibacterial activity of AM-1155 was almost equal to that of sparfloxacin. The in vivo efficacy of AM-1155 was evaluated using a polymicrobial pyometra (E. coli and B. fragilis) model of rats. The accumulation of neutrophils to the uterus in the AM-1155-treated group was less marked than that of the nontreated group, as well as the bacteriological response. These results suggest that the new antimicrobial agent AM-1155 might be useful for the treatment of polymicrobial infections in the fields of obstetrics and gynecology.
AM - 1155是一种新型的8 - 甲氧基喹诺酮羧酸,具有广谱抗菌活性。在浓度为3.13毫克/升时,它能抑制超过90%的无乳链球菌、大肠杆菌、大消化链球菌、脆弱拟杆菌和二路普雷沃菌的临床分离株。AM - 1155的抗菌活性几乎与司帕沙星相当。使用大鼠多微生物性子宫积脓(大肠杆菌和脆弱拟杆菌)模型评估了AM - 1155的体内疗效。与未治疗组相比,AM - 1155治疗组中性粒细胞在子宫内的聚集以及细菌学反应均不明显。这些结果表明,新型抗菌剂AM - 1155可能对治疗妇产科领域的多微生物感染有用。